Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide (FHIR R4), published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health-ips/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "gravitate-Matilda",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Bundle-uv-ips"
]
},
"identifier" : {
"system" : "https://www.gravitatehealth.eu/sid/doc",
"value" : "Matilda-ips-1"
},
"type" : "document",
"timestamp" : "2021-04-18T09:22:00+02:00",
"entry" : [
{
"fullUrl" : "https://myserver.org/Composition/matilda-comp",
"resource" : {
"resourceType" : "Composition",
"id" : "gravitate-Matilda",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>Id:</b> gravitate-Matilda<br/><b>status:</b> final<br/><b>Type:</b> Patient summary Document<br/><b>Subject:</b> Matilda Gravitate<br/><b>Sections:</b><br/><ul><li><b>Title:</b> Problem List<br/><b>Code:</b> Problem list Reported (11450-4)</li><br/><ul><li><b>Entry:</b> <a href=\"Condition-matilda-cond-1.html\">Crohn's disease</a></li><br/></ul><li><b>Title:</b> Medication Summary<br/><b>Code:</b> Hx of Medication use (10160-0)</li><br/><ul><li><b>Entry:</b> <a href=\"MedicationStatement-matilda-med-stat-1.html\">Humira 40 mg</a></li><br/><li><b>Entry:</b> <a href=\"MedicationStatement-matilda-med-stat-2.html\">Paracetamol 500 mg</a></li><br/><li><b>Entry:</b> <a href=\"MedicationStatement-matilda-med-stat-3.html\">Pentasa 1g mesalazine</a></li><br/></ul></ul></div>"
},
"status" : "final",
"type" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "60591-5",
"display" : "Patient summary Document"
}
]
},
"subject" : {
"reference" : "Patient/matilda-patient",
"display" : "Matilda Gravitate"
},
"date" : "2018-07-10T15:22:00+02:00",
"author" : [
{
"reference" : "Practitioner/matilda-pract",
"display" : "Dr. Ana Lopez"
}
],
"title" : "Patient Summary (Matilda Gravitate)",
"confidentiality" : "N",
"section" : [
{
"title" : "Problem List",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "11450-4",
"display" : "Problem list Reported"
}
]
},
"entry" : [
{
"reference" : "Condition/matilda-cond-1",
"display" : "Crohn's disease"
}
]
},
{
"title" : "Medication Summary",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "10160-0",
"display" : "Hx of Medication use"
}
]
},
"entry" : [
{
"reference" : "MedicationStatement/matilda-med-stat-1",
"display" : "Humira 40 mg"
},
{
"reference" : "MedicationStatement/matilda-med-stat-2",
"display" : "Paracetamol 500 mg"
},
{
"reference" : "MedicationStatement/matilda-med-stat-3",
"display" : "Pentasa 1g mesalazine"
}
]
}
]
}
},
{
"fullUrl" : "https://myserver.org/Patient/matilda-patient",
"resource" : {
"resourceType" : "Patient",
"id" : "matilda-patient",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Patient_matilda-patient\"> </a><p><b>Generated Narrative: Patient</b><a name=\"matilda-patient\"> </a><a name=\"hcmatilda-patient\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourcePatient "matilda-patient" </p></div><blockquote><p><b>Patient Citizenship</b></p><blockquote><p><b>url</b></p><a href=\"http://hl7.org/fhir/R4/datatypes.html#code\">code</a></blockquote><p><b>value</b>: Spain <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#ES)</span></p></blockquote><p><b>identifier</b>: <code>https://www.gravitatehealth.eu/sid/doc</code>/Matilda-1</p><p><b>active</b>: true</p><p><b>name</b>: Matilda Gravitate </p><p><b>gender</b>: female</p><p><b>birthDate</b>: 1950-09-01</p></div>"
},
"extension" : [
{
"extension" : [
{
"url" : "code",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "ES",
"display" : "Spain"
}
]
}
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/patient-citizenship"
}
],
"identifier" : [
{
"system" : "https://www.gravitatehealth.eu/sid/doc",
"value" : "Matilda-1"
}
],
"active" : true,
"name" : [
{
"family" : "Gravitate",
"given" : [
"Matilda"
]
}
],
"gender" : "female",
"birthDate" : "1950-09-01"
}
},
{
"fullUrl" : "https://myserver.org/Practitioner/matilda-pract",
"resource" : {
"resourceType" : "Practitioner",
"id" : "matilda-pract",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Practitioner_matilda-pract\"> </a><p><b>Generated Narrative: Practitioner</b><a name=\"matilda-pract\"> </a><a name=\"hcmatilda-pract\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourcePractitioner "matilda-pract" </p></div><p><b>name</b>: Ana Lopez </p></div>"
},
"name" : [
{
"family" : "Lopez",
"given" : [
"Ana"
],
"prefix" : [
"Dr."
]
}
]
}
},
{
"fullUrl" : "https://myserver.org/Condition/matilda-cond-1",
"resource" : {
"resourceType" : "Condition",
"id" : "matilda-cond-1",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Condition_matilda-cond-1\"> </a><p><b>Generated Narrative: Condition</b><a name=\"matilda-cond-1\"> </a><a name=\"hcmatilda-cond-1\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceCondition "matilda-cond-1" </p></div><p><b>clinicalStatus</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-condition-clinical.html\">Condition Clinical Status Codes</a>#active)</span></p><p><b>code</b>: Crohn's disease <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOWMED CT</a>#34000006)</span></p><p><b>subject</b>: See on this page: Patient/matilda-patient: Matilda Gravitate</p><p><b>onset</b>: 2015</p><p><b>asserter</b>: See on this page: Practitioner/matilda-pract: Dr. Ana Lopez</p></div>"
},
"clinicalStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
"code" : "active"
}
]
},
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "34000006",
"display" : "Crohn's disease"
}
],
"text" : "Crohn's disease"
},
"subject" : {
"reference" : "Patient/matilda-patient",
"display" : "Matilda Gravitate"
},
"onsetDateTime" : "2015",
"asserter" : {
"reference" : "Practitioner/matilda-pract",
"display" : "Dr. Ana Lopez"
}
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/matilda-med-stat-1",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "matilda-med-stat-1",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationStatement_matilda-med-stat-1\"> </a><p><b>Generated Narrative: MedicationStatement</b><a name=\"matilda-med-stat-1\"> </a><a name=\"hcmatilda-med-stat-1\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedicationStatement "matilda-med-stat-1" </p></div><p><b>status</b>: active</p><p><b>medication</b>: See on this page: Medication/9d7be868-8264-4d94-ad04-ef04ecc92e51: Humira 40 mg</p><p><b>subject</b>: See on this page: Patient/matilda-patient: Matilda Gravitate</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td></tr><tr><td style=\"display: none\">*</td><td>Subcutaneous use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20066000)</span></td></tr></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/9d7be868-8264-4d94-ad04-ef04ecc92e51",
"display" : "Humira 40 mg"
},
"subject" : {
"reference" : "Patient/matilda-patient",
"display" : "Matilda Gravitate"
},
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20066000",
"display" : "Subcutaneous use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/matilda-med-stat-2",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "matilda-med-stat-2",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationStatement_matilda-med-stat-2\"> </a><p><b>Generated Narrative: MedicationStatement</b><a name=\"matilda-med-stat-2\"> </a><a name=\"hcmatilda-med-stat-2\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedicationStatement "matilda-med-stat-2" </p></div><p><b>status</b>: active</p><p><b>medication</b>: See on this page: Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7et: PARACETAMOL 1000 MG</p><p><b>subject</b>: See on this page: Patient/matilda-patient: Matilda Gravitate</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td></tr><tr><td style=\"display: none\">*</td><td>Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20053000)</span></td></tr></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7et",
"display" : "PARACETAMOL 1000 MG"
},
"subject" : {
"reference" : "Patient/matilda-patient",
"display" : "Matilda Gravitate"
},
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20053000",
"display" : "Oral use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/matilda-med-stat-3",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "matilda-med-stat-3",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationStatement_matilda-med-stat-3\"> </a><p><b>Generated Narrative: MedicationStatement</b><a name=\"matilda-med-stat-3\"> </a><a name=\"hcmatilda-med-stat-3\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedicationStatement "matilda-med-stat-3" </p></div><p><b>status</b>: active</p><p><b>medication</b>: See on this page: Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7eu: Pentasa 1g mesalazine</p><p><b>subject</b>: See on this page: Patient/matilda-patient: Matilda Gravitate</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td></tr><tr><td style=\"display: none\">*</td><td>Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20053000)</span></td></tr></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7eu",
"display" : "Pentasa 1g mesalazine"
},
"subject" : {
"reference" : "Patient/matilda-patient",
"display" : "Matilda Gravitate"
},
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20053000",
"display" : "Oral use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/9d7be868-8264-4d94-ad04-ef04ecc92e51",
"resource" : {
"resourceType" : "Medication",
"id" : "9d7be868-8264-4d94-ad04-ef04ecc92e51",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_9d7be868-8264-4d94-ad04-ef04ecc92e51\"> </a><p><b>Generated Narrative: Medication</b><a name=\"9d7be868-8264-4d94-ad04-ef04ecc92e51\"> </a><a name=\"hc9d7be868-8264-4d94-ad04-ef04ecc92e51\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedication "9d7be868-8264-4d94-ad04-ef04ecc92e51" </p></div><p><b>code</b>: Humira 40 mg <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (pmswi#EU/1/03/256/022; phpid#0xe72f98caa2b13cb3ccb489a1a7945c91 "Humira 40 mg solution for injection in pre-filled syringe 2 pre-filled syringes + 2 alcohol pads"; <a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-WC.html\">WHO ATC</a>#L04AB04 "adalimumab")</span></p><p><b>form</b>: Solution for injection <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#11201000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td style=\"display: none\">*</td><td>adalimumab <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#FYS6T7F842)</span></td><td>40 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 ml<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code ml = 'ml')</span></td></tr></table></div>"
},
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"code" : "EU/1/03/256/022",
"display" : "Humira 40 mg"
},
{
"system" : "https://www.who-umc.org/phpid",
"code" : "0xe72f98caa2b13cb3ccb489a1a7945c91",
"display" : "Humira 40 mg solution for injection in pre-filled syringe 2 pre-filled syringes + 2 alcohol pads"
},
{
"system" : "http://www.whocc.no/atc",
"code" : "L04AB04",
"display" : "adalimumab"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "11201000",
"display" : "Solution for injection"
}
]
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "FYS6T7F842",
"display" : "adalimumab"
}
],
"text" : "adalimumab"
},
"strength" : {
"numerator" : {
"value" : 40,
"system" : "http://unitsofmeasure.org",
"code" : "mg"
},
"denominator" : {
"value" : 1,
"system" : "http://unitsofmeasure.org",
"code" : "ml"
}
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7et",
"resource" : {
"resourceType" : "Medication",
"id" : "fdb5c97f-0a46-41ba-bc34-2efd2ef2f7et",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_fdb5c97f-0a46-41ba-bc34-2efd2ef2f7et\"> </a><p><b>Generated Narrative: Medication</b><a name=\"fdb5c97f-0a46-41ba-bc34-2efd2ef2f7et\"> </a><a name=\"hcfdb5c97f-0a46-41ba-bc34-2efd2ef2f7et\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedication "fdb5c97f-0a46-41ba-bc34-2efd2ef2f7et" </p></div><p><b>code</b>: DOLOCATIL 1 g tablets <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (pmswi#72.741; phpid#0xE857DA811B4A6F3BD57810C45D2EA1ED "Paracetamol 1g tablets"; <a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-WC.html\">WHO ATC</a>#N02BE01 "paracetamol")</span></p><p><b>form</b>: Coated tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10220000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td style=\"display: none\">*</td><td>ACETAMINOPHEN <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#362O9ITL9D)</span></td><td>1000 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: standardterms.edqm.eu code 15054000 = 'Tablet')</span></td></tr></table></div>"
},
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"code" : "72.741",
"display" : "DOLOCATIL 1 g tablets"
},
{
"system" : "https://www.who-umc.org/phpid",
"code" : "0xE857DA811B4A6F3BD57810C45D2EA1ED",
"display" : "Paracetamol 1g tablets"
},
{
"system" : "http://www.whocc.no/atc",
"code" : "N02BE01",
"display" : "paracetamol"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "10220000",
"display" : "Coated tablet"
}
]
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "362O9ITL9D",
"display" : "ACETAMINOPHEN"
}
],
"text" : "ACETAMINOPHEN"
},
"strength" : {
"numerator" : {
"value" : 1000,
"system" : "http://unitsofmeasure.org",
"code" : "mg"
},
"denominator" : {
"value" : 1,
"unit" : "Tablet",
"system" : "http://standardterms.edqm.eu",
"code" : "15054000"
}
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/fdb5c97f-0a46-41ba-bc34-2efd2ef2f7eu",
"resource" : {
"resourceType" : "Medication",
"id" : "fdb5c97f-0a46-41ba-bc34-2efd2ef2f7eu",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_fdb5c97f-0a46-41ba-bc34-2efd2ef2f7eu\"> </a><p><b>Generated Narrative: Medication</b><a name=\"fdb5c97f-0a46-41ba-bc34-2efd2ef2f7eu\"> </a><a name=\"hcfdb5c97f-0a46-41ba-bc34-2efd2ef2f7eu\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedication "fdb5c97f-0a46-41ba-bc34-2efd2ef2f7eu" </p></div><p><b>code</b>: Pentasa Slow Release Tablets 1g <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (pmswi#77022; phpid#0xF79CABF272B6A7EEF104DDDA44E827xx "Mesalazine, 1g, Tablets"; <a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-WC.html\">WHO ATC</a>#A07EC02 "mesalazine")</span></p><p><b>form</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10219000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td style=\"display: none\">*</td><td>MESALAMINE <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#4Q81I59GXC)</span></td><td>1000 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: standardterms.edqm.eu code 15054000 = 'Tablet')</span></td></tr></table></div>"
},
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"code" : "77022",
"display" : "Pentasa Slow Release Tablets 1g"
},
{
"system" : "https://www.who-umc.org/phpid",
"code" : "0xF79CABF272B6A7EEF104DDDA44E827xx",
"display" : "Mesalazine, 1g, Tablets"
},
{
"system" : "http://www.whocc.no/atc",
"code" : "A07EC02",
"display" : "mesalazine"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "10219000",
"display" : "Tablet"
}
],
"text" : "Tablet"
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "4Q81I59GXC",
"display" : "MESALAMINE"
}
],
"text" : "MESALAMINE"
},
"strength" : {
"numerator" : {
"value" : 1000,
"system" : "http://unitsofmeasure.org",
"code" : "mg"
},
"denominator" : {
"value" : 1,
"unit" : "Tablet",
"system" : "http://standardterms.edqm.eu",
"code" : "15054000"
}
}
}
]
}
}
]
}
IG © 2021+ . Package hl7.eu.fhir.gh-ips#0.1.0 based on FHIR 4.0.1. Generated 2024-05-14
Links: Table of Contents |
QA Report
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.
